Profil
William Fricker formerly worked at Immunomedics, Inc., as Controller from 2018 to 2020, Eleison Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2023, NRX Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer in 2021, J.
M.
Huber Micropowders, Inc., as VP, Global Controller & Chief Accounting Officer, NeuroTrauma Sciences LLC, as Chief Financial Officer from 2023 to 2024, and Annovis Bio, Inc., as Chief Financial Officer from 2024 to 2025.
Mr. Fricker received his undergraduate degree from The Pennsylvania State University.
Anciens postes connus de William Fricker
| Sociétés | Poste | Fin |
|---|---|---|
| ANNOVIS BIO, INC. | Directeur Financier/CFO | 27/03/2025 |
NeuroTrauma Sciences LLC
NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Directeur Financier/CFO | 01/04/2024 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Directeur Financier/CFO | 01/01/2023 |
| NRX PHARMACEUTICALS, INC. | Directeur Financier/CFO | 30/08/2021 |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 01/10/2020 |
Formation de William Fricker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Annovis Bio, Inc.
Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes clinical stage drug candidates for orphan cancers | Health Technology |
NeuroTrauma Sciences LLC
NeuroTrauma Sciences LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat brain injury | Health Technology |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
J. M. Huber Micropowders, Inc.
J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Manufactures chemicals and minerals | Process Industries |
















